nach oben

Reactions Weekly

Erschienen in:

01.09.2017 | Case report

Infliximab

Infusion reaction: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

In a prospective, observational, multi center study, two patients [ages and sexes not stated] were described, who developed infusion reaction following treatment with infliximab [Inflectra]. The patients who had a history of Crohn's disease (one patient) and ulcerative colitis (one patient), started receiving treatment with IV infliximab 5 mg/kg infusion. Subsequently, both the patients developed infusion reaction [durations of treatments to reactions onset and outcomes not stated]. …

Balint A, et al. Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. Expert Opinion on Drug Safety 16: 885-890, No. 8, 2017. Available from: URL: http://doi.org/10.1080/14740338.2017.1323330 - HungarCrossRefPubMed

Titel: Infliximab
Infusion reaction: 2 case reports
Publikationsdatum: 01.09.2017
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-36048-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Infliximab

Infusion reaction: 2 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Codeine/ranitidine

FDA warning of CGMP violations related to EpiPens

Valproate

Emtricitabine/tenofovir disoproxil fumarate/etravirine

Omeprazole

Rituximab